Orforglipron helped keep weight down when used after initial therapy with an injectable, a new treatment strategy that could ...
Lilly’s Attain-Maintain Phase III results show that the oral GLP-1 orforglipron can effectively preserve weight loss after injectable therapy, positioning it as a potential long-term maintenance ...
The pharmaceutical leader has established itself as the leader in the fast-growing weight loss market. And although many ...
The survey showed that while most of the doctors didn’t have top-of-mind awareness of oral semaglutide’s upcoming FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback